Us Congress 2025-2026 Regular Session All Bills (Page 539)

Page 539 of 613
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB419

Introduced
2/5/25  
Refer
2/5/25  
A bill to amend the Omnibus Crime Control and Safe Streets Act of 1968 to reauthorize grants to support law enforcement officers and families, and for other purposes.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB42

Introduced
1/9/25  
<p><strong>Build the Wall Act of 2025</strong></p><p>This bill establishes the Southern Border Wall Construction Fund to be used by the Department of Homeland Security to construct and maintain physical barriers along the U.S.-Mexico border. All unobligated amounts in the Coronavirus State and Local Fiscal Recovery Funds must be immediately deposited in the Southern Border Wall Construction Fund.</p>
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB420

Introduced
2/5/25  
<p><strong>Dairy Business Innovation Act of 2025</strong></p><p>This bill increases the authorization of appropriations for the Dairy Business Innovation&nbsp;(DBI) Initiatives<strong> </strong>for each fiscal year. Under the Agricultural Marketing Service, the&nbsp;DBI Initiatives support dairy businesses in the development, production, marketing, and distribution of dairy products. The DBI Initiatives provide direct technical assistance and subawards to dairy businesses, including for niche dairy products and dairy products derived from cow milk, sheep milk, and goat milk.</p>
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB421

Introduced
2/5/25  
A bill to amend the Agricultural Marketing Act of 1946 to establish country of origin labeling requirements for beef, and for other purposes.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB422

Introduced
2/5/25  
A bill to protect an individual's ability to access contraceptives and to engage in contraception and to protect a health care provider's ability to provide contraceptives, contraception, and information related to contraception.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB423

Introduced
2/5/25  
Refer
2/5/25  
Engrossed
4/9/25  
Enrolled
8/12/25  
Passed
8/14/25  
Chaptered
8/14/25  
A bill to protect regular order for budgeting for the Department of Veterans Affairs, and for other purposes.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB424

Introduced
2/5/25  
A bill to amend the Federal securities laws to enhance 403(b) plans, and for other purposes.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB425

Introduced
2/5/25  
A bill to amend the Internal Revenue Code of 1986 to modify the carbon oxide sequestration credit to ensure parity for different uses and utilizations of qualified carbon oxide.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB426

Introduced
2/5/25  
A bill to provide for modifications to ending trafficking in government contracting, and for other purposes.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB427

Introduced
2/5/25  
Refer
2/5/25  
A bill to require the Federal financial institutions regulatory agencies to take risk profiles and business models of institutions into account when taking regulatory actions, and for other purposes.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB428

Introduced
2/5/25  
Refer
2/5/25  
A bill to promote space situational awareness and space traffic coordination and to modify the functions and leadership of the Office of Space Commerce, and for other purposes.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB429

Introduced
2/5/25  
A bill to enhance the economic and national security of the United States by securing a reliable supply of critical minerals and rare earth elements through trade agreements and strategic partnerships.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB43

Introduced
1/9/25  
<p><strong>Skinny Labels, Big Savings Act</strong></p><p>This bill provides a statutory safe harbor from patent infringement claims for generic or&nbsp;biosimilar manufacturers that seek or obtain approval for skinny labels of their drugs.</p><p>Under current law, the Food and Drug Administration (FDA) may approve generic and&nbsp;biosimilar drugs through a process known as skinny labeling, which allows a generic manufacturer to seek approval only for approved uses of the drug that are no longer protected by patents. However, in <em>GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc.</em>, a court held that a generic manufacturer may sometimes be liable for patent infringement when it markets skinny label generics.</p><p>The bill specifically lists the following as actions that are not considered infringement of a method of use claim in a patent under the Federal Food, Drug, and Cosmetic Act:</p><ul><li>submitting or seeking approval of a skinny label for a generic or biosimilar drug;</li><li>promoting or commercially marketing a drug with skinny labeling approved by the FDA; or</li><li>describing a drug product approved by the FDA as a generic of, or therapeutically equivalent to, the branded drug.</li></ul><p>The bill also applies the safe harbor to similar actions under the Public Health Service Act.</p>
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB430

Introduced
2/5/25  
A bill to require sellers of event tickets to disclose comprehensive information to consumers about ticket prices and related fees.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB431

Introduced
2/5/25  
A bill to amend section 1030 of title 18, United States Code, to include conspiracy in the offenses and penalties relating to computer fraud.

Research Filters

States
Terms / Sessions
Chamber Records